Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Pharmacokinetics, pharmacodynamics and safety of i.v. RGD-891 studied in healthy volunteers

Oct. 24, 2000

Novel compounds identified at Merck as factor Xa inhibitors

Oct. 19, 2000

International patent coverage obtained for new thrombin inhibitors from Boehringer Ingelheim

Oct. 10, 2000

IND filed by Endovasc for Liprostin

Oct. 5, 2000

BLA supplement filed for alteplase

Oct. 4, 2000

New factor Xa inhibitors with therapeutic and diagnostic uses

Sep. 27, 2000

Lactam factor Xa inhibitors designed by BMS research groups

Sep. 26, 2000

Factor Xa inhibitors synthesized and tested at AstraZeneca

Sep. 22, 2000

Time to ambulation following angioplasty reduced on Neutralase

Sep. 21, 2000

Promising data reported from phase II trial of injectable anticoagulant

Sep. 20, 2000

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...